# EDGAR Filing Document

**Accession Number:** 0001849296
**File Stem:** 0001493152-23-000458
**Filing Date:** 2023-1
**Character Count:** 1919
**Document Hash:** e8bd73554df24992ca5334cc9b4f9d99
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-000458.hdr.sgml**: 20230328

**ACCESSION NUMBER**: 0001493152-23-000458

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230105

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** OKYO Pharma Ltd
- **CENTRAL INDEX KEY:** 0001849296
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 000000000

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 55 PARK LANE
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** W1K 1NA
- **BUSINESS PHONE:** 44 (0) 207 495 2379

**MAIL ADDRESS:**
- **STREET 1:** 55 PARK LANE
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** W1K 1NA

**OKYO Pharma Ltd.**

**Martello Court** 

**Admiral Park**

**St. Peter Court**

**Guernsey GY1 3HB**

January 5, 2023

**<u>VIA EDGAR</u>**

United States Securities

and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Tyler Howes

---

| | |
|:---|:---|
| **Re:** | **OKYO Pharma Ltd.** |
|  | **Registration Statement on Form F-1/A** |
|  | **File No. 333-268675** |

---

Ladies and Gentlemen:

OKYO Pharma Ltd. (the "Company") hereby respectfully withdraws its request, dated January 3, 2023, that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Thursday, January 5, 2023. The Company intends to submit a revised acceleration request at a later date.

Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 if there are any question with respect to this request.

---

| | |
|:---|:---|
| Thank you, | Thank you, |
| **OKYO PHARMA LTD.** | **OKYO PHARMA LTD.** |
| By: | */s/ Gary S. Jacob* |
| **Name:** | **Gary S. Jacob** |
| Title: | Chief Executive Officer |

---